AspirinClot RetractionBlood CoagulationFibrinFibrinolysisThrombelastographyThrombosisTissue Plasminogen ActivatorFibrinogenFibrinolytic AgentsFactor XIIIaBlood Coagulation TestsUltrasonic TherapyHemostaticsPlatelet Aggregation InhibitorsHemoglobin HPlasminogenHemostasisPulmonary EmbolismHigh-Intensity Focused Ultrasound AblationFactor XIIIalpha-2-AntiplasminFibrinolysinBlood PlateletsAnti-Inflammatory Agents, Non-SteroidalThrombinBlood Coagulation DisordersPlatelet ActivationIntracranial EmbolismCerebral HemorrhageThrombolytic TherapyStreptokinaseHemorrhageSubarachnoid HemorrhageHeparinBloodPlasminogen ActivatorsTime FactorsPlatelet AggregationRabbitsTiclopidineThromboxane B2DogsStrokeCyclooxygenase InhibitorsDisease Models, AnimalPlatelet Function TestsSalicylatesRecombinant ProteinsTreatment OutcomeFibrin Clot Lysis TimeAnticoagulantsDrug Therapy, CombinationBleeding TimeSodium SalicylateSwineWarfarinKineticsAsthma, Aspirin-InducedGastrointestinal HemorrhageTablets, Enteric-CoatedDose-Response Relationship, DrugCyclooxygenase 1Prostaglandin-Endoperoxide SynthasesThromboxanesFibrinogens, AbnormalIbuprofenThromboxane A2Nephelometry and TurbidimetryDouble-Blind MethodCarboxypeptidase UIntracranial ThrombosisCyclooxygenase 2 InhibitorsRisk FactorsDipyridamolePlatelet Glycoprotein GPIIb-IIIa ComplexMyocardial InfarctionDrug ResistanceLipoxinsProspective StudiesAcetaminophenFibrin Fibrinogen Degradation ProductsThromboembolismIndomethacinFibrinopeptide BSulfinpyrazoneGastric MucosaCyclooxygenase 2Reye SyndromePeptic Ulcer HemorrhageStomach UlcerProstaglandinsNaproxen